Related Experiment Video

Updated: May 18, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Innate inflammation in Parkinson's disease

V Hugh Perry1

  • 1School of Biological Sciences, University of Southampton, Southampton, UK. vhp@soton.ac.uk

Cold Spring Harbor Perspectives in Medicine
|September 7, 2012
PubMed

Insights

Microglia, the brain's immune cells, show changes in Parkinson's disease. Research must carefully consider human comorbidities and animal model limitations for accurate insights into this neurodegenerative disease.

Area of Science:

  • Neuroimmunology
  • Neurodegeneration
  • Parkinson's Disease Pathogenesis

Background:

  • Microglia, the brain's resident macrophages, are activated during Parkinson's disease progression.
  • The role of this innate immune response in Parkinson's pathogenesis and progression is under investigation.
  • Existing research includes observational studies in human postmortem tissue and animal models.

Purpose of the Study:

  • To review key conceptual issues in studying microglial contributions to Parkinson's disease.
  • To highlight limitations in current research methodologies.
  • To critically assess the extrapolation of findings from animal models to human Parkinson's disease.

Main Methods:

  • Review of observational studies in human postmortem material.
  • Analysis of studies utilizing animal models of Parkinson's disease.
  • Critical evaluation of conceptual issues in neuroinflammation research.

Main Results:

  • Most postmortem studies overlook the impact of comorbidities in Parkinson's disease patients.
  • Animal models have limitations when applied to chronic, long-term human neurodegenerative diseases.
  • Extrapolation of animal model findings to human Parkinson's disease requires careful consideration.

Conclusions:

  • Understanding microglial roles in Parkinson's disease requires addressing methodological challenges.
  • Comorbidities significantly complicate the interpretation of human postmortem studies.
  • Animal models offer valuable insights but have inherent limitations for modeling chronic human neurodegeneration.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...